Metabolomic and Pharmacological Evidence for Redox-Associated and Ras-Related Processes in Clostridium perfringens Epsilon Toxin-Induced Human Erythrocyte Hemolysis
Pathogens · 16.11.2026 · 15 (11) · 1201
DOI: 10.3390/pathogens15111201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 16.11.2026. Verfasst von Qian Wang und 11 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Key Laboratory of Pathogen and Biosecurity.
Abstract (Originalsprache)
Clostridium perfringens epsilon toxin (ETX), produced by type B and D strains, is a highly potent pore-forming toxin that causes rapid hemolysis of human erythrocytes. Previous studies implicated P2X7/P2Y13 purinergic receptors and MAL protein in this selectivity, but downstream events remain unclear. We used an exploratory, hypothesis-generating design combining LC-MS/NMR metabolomics with amino acid, antioxidant, and pharmacological interventions. ETX treatment was accompanied by widespread decreases in metabolite abundance, with alanine, aspartate and glutamate metabolism being the most affected annotated pathway. L-Methionine, L-histidine, L-cysteine, L-lysine, and high concentrations of L-aspartate reduced ETX-induced hemolysis to varying extents. N-Acetyl-L-cysteine (NAC) reduced hemolysis, whereas the NADPH oxidase inhibitor diphenyleneiodonium (DPI) did not. Inhibitors associated with PI3K/Akt (perifosine, API-2), MEK/ERK (BIX02189, TCS ERK 11e), and Ras/Raf (Kobe0065, Antineoplaston A10, LY3009120) also reduced hemolysis. These observations are consistent with redox-associated and Ras-related processes, but they do not demonstrate activation of these pathways: Ras-GTP, Akt/ERK phosphorylation, kinase activity, ROS, and glutathione status were not measured, and immunoblotting for phospho-Akt/ERK was inconclusive. Protective effects generally required high, often supraphysiological concentrations, and nonspecific physicochemical effects cannot be excluded. The study therefore provides preliminary, hypothesis-generating evidence and defines the direct biochemical experiments required to test the proposed model.
Förderung
- State Key Laboratory of Pathogen and Biosecurity
Zitieren
APA
Wang, Q., Chen, M., Jiang, L., Yue, N., Lan, H., Nie, Y., Yuan, Y., Gao, S., Yuan, B., Li, J., Kang, L., & Xin, W. (2026). Metabolomic and Pharmacological Evidence for Redox-Associated and Ras-Related Processes in Clostridium perfringens Epsilon Toxin-Induced Human Erythrocyte Hemolysis. Pathogens, 15(11), 1201. https://doi.org/10.3390/pathogens15111201
Vancouver
Wang Q, Chen M, Jiang L, Yue N, Lan H, Nie Y, et al. Metabolomic and Pharmacological Evidence for Redox-Associated and Ras-Related Processes in Clostridium perfringens Epsilon Toxin-Induced Human Erythrocyte Hemolysis. Pathogens. 2026;15(11):1201. doi:10.3390/pathogens15111201
BibTeX
@article{Wang2026,
author = {Wang, Qian and Chen, Ming and Jiang, Linying and Yue, Nan and Lan, Huan and Nie, Yaling and Yuan, Yuan and Gao, Shan and Yuan, Bing and Li, Jiaxin and Kang, Lin and Xin, Wenwen},
title = {Metabolomic and Pharmacological Evidence for Redox-Associated and Ras-Related Processes in Clostridium perfringens Epsilon Toxin-Induced Human Erythrocyte Hemolysis},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {11},
pages = {1201},
doi = {10.3390/pathogens15111201}
}
EUVIMED